I would like to Re-direct this discussion back to the original question: Is it advisable and safe for a transplant patient to get the new shingles vaccine?

Shingles a viral infection that causes a painful rash. It is caused by the varicella-zoster virus — the same virus that causes chicken-pox. Vaccines can help reduce the risk of shingles. Here is information about the causes, risk factors, complications and prevention (vaccine) for shingles. Shingles - https://www.mayoclinic.org/diseases-conditions/shingles/symptoms-causes/syc-20353054

Shingrix was approved by the FDA in 2017 and is the preferred alternative to Zostavax. Studies suggest Shingrix offers protection against shingles beyond five years. It's a nonliving vaccine made of a virus component, and is given in two doses, with two to six months between doses.
Shingrix is approved and recommended for people age 50 and older, including those who've previously received Zostavax. Zostavax isn't recommended until age 60.
Zoster Vaccine Recombinant, Adjuvanted (Intramuscular Route) - https://www.mayoclinic.org/drugs-supplements/zoster-vaccine-recombinant-adjuvanted-intramuscular-route/description/drg-20406737

I had the original shingles (live) vaccine right before I was placed on the transplant list because my Mayo team knew (in 2009) that I would not be eligible for the live vaccine after a transplant. My first transplant team did not even mention it to me. When the new Shingrix was approved by FDA in 2017, Mayo okeyed it for me when I inquired about it. My transplanted organs are a liver and a kidney and my age fit the standard requirements.

@jodeej, @gaylea1, @jolinda, - Have you any update about asking your doctor?
@azdan99, We look forward to hearing from you after your appointment.
@estrada53, How are you doing? Did you get the 1st shot?